IS5237A - Efnasambönd - Google Patents

Efnasambönd

Info

Publication number
IS5237A
IS5237A IS5237A IS5237A IS5237A IS 5237 A IS5237 A IS 5237A IS 5237 A IS5237 A IS 5237A IS 5237 A IS5237 A IS 5237A IS 5237 A IS5237 A IS 5237A
Authority
IS
Iceland
Prior art keywords
compounds
Prior art date
Application number
IS5237A
Other languages
English (en)
Inventor
Macdonald James
Matz James
Shakespeare William
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS5237A publication Critical patent/IS5237A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS5237A 1997-05-05 1999-11-01 Efnasambönd IS5237A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701682A SE9701682D0 (sv) 1997-05-05 1997-05-05 Compounds
PCT/SE1998/000792 WO1998050380A1 (en) 1997-05-05 1998-04-28 Compounds

Publications (1)

Publication Number Publication Date
IS5237A true IS5237A (is) 1999-11-01

Family

ID=20406836

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5237A IS5237A (is) 1997-05-05 1999-11-01 Efnasambönd

Country Status (28)

Country Link
US (1) US6166030A (is)
EP (1) EP0983266B1 (is)
JP (1) JP2001523263A (is)
KR (1) KR20010012227A (is)
CN (1) CN1255130A (is)
AR (1) AR012602A1 (is)
AT (1) ATE210661T1 (is)
AU (1) AU734394B2 (is)
BR (1) BR9808725A (is)
CA (1) CA2287999A1 (is)
DE (1) DE69802923T2 (is)
DK (1) DK0983266T3 (is)
EE (1) EE9900475A (is)
ES (1) ES2168757T3 (is)
HU (1) HUP0003766A3 (is)
ID (1) ID23156A (is)
IL (1) IL132677A0 (is)
IS (1) IS5237A (is)
MX (1) MXPA99009874A (is)
NO (1) NO995404L (is)
NZ (1) NZ500676A (is)
PL (1) PL336854A1 (is)
PT (1) PT983266E (is)
SE (1) SE9701682D0 (is)
SK (1) SK140699A3 (is)
TR (1) TR199902719T2 (is)
WO (1) WO1998050380A1 (is)
ZA (1) ZA983740B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001024826A2 (en) * 1999-10-06 2001-04-12 The Brigham And Women's Hospital, Inc. Inrease of enos activity through activation of the pi3-kinase/akt pathway by estrogens
US7115653B2 (en) * 2000-03-30 2006-10-03 Curis, Inc. Small organic molecule regulators of cell proliferation
US6683108B1 (en) * 2000-03-30 2004-01-27 Curis, Inc. Agonists of hedgehog signaling pathways and uses related thereto
US8852937B2 (en) * 2000-03-30 2014-10-07 Curis, Inc. Small organic molecule regulators of cell proliferation
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
EP1497283A4 (en) * 2002-03-22 2006-01-11 Lg Life Sciences Ltd (2S) -N-5-AMINO (IMINO) METHYL-2-THIENYL METHYL-1- (2R) -2- (CARBOXYMETHYL) AMINO) 3,3-DIPHENYLPROPANOYL -2-PYRROLIDINE CARBOXAMIDE MALEIC ACID SALT AND PROCESS OF PREPARATION CORRESPONDING
ATE489138T1 (de) 2005-04-13 2010-12-15 Neuraxon Inc Substituierte indolverbindungen mit nos-hemmender aktivität
US8173813B2 (en) * 2007-03-23 2012-05-08 Neuraxon, Inc. Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity
EA201000808A1 (ru) 2007-11-16 2011-04-29 Ньюраксон, Инк. Индольные соединения и способы лечения висцеральной боли

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK16396A3 (en) * 1993-08-12 1996-09-04 Astra Ab Amidine derivatives with nitric oxide synthetase activities
EP0723438A1 (en) * 1993-10-04 1996-07-31 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
AU688811B2 (en) * 1993-10-21 1998-03-19 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
US5807886A (en) * 1994-05-07 1998-09-15 Astra Aktiebolag Bicyclic amidine dervatives as inhibitors of nitric oxide synthetase
CZ287969B6 (cs) * 1995-08-10 2001-03-14 Astra Pharmaceuticals Limited Amidinový derivát, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a použití

Also Published As

Publication number Publication date
PL336854A1 (en) 2000-07-17
NZ500676A (en) 2001-05-25
SK140699A3 (en) 2000-06-12
HUP0003766A2 (en) 2001-03-28
AU734394B2 (en) 2001-06-14
CN1255130A (zh) 2000-05-31
ES2168757T3 (es) 2002-06-16
ID23156A (id) 2000-03-23
DK0983266T3 (da) 2002-03-11
WO1998050380A1 (en) 1998-11-12
AR012602A1 (es) 2000-11-08
PT983266E (pt) 2002-05-31
AU7460098A (en) 1998-11-27
ZA983740B (en) 1999-02-19
TR199902719T2 (xx) 2000-02-21
HUP0003766A3 (en) 2001-09-28
EE9900475A (et) 2000-06-15
CA2287999A1 (en) 1998-11-12
IL132677A0 (en) 2001-03-19
JP2001523263A (ja) 2001-11-20
SE9701682D0 (sv) 1997-05-05
DE69802923T2 (de) 2002-07-04
BR9808725A (pt) 2000-07-11
DE69802923D1 (de) 2002-01-24
EP0983266A1 (en) 2000-03-08
NO995404L (no) 2000-01-05
US6166030A (en) 2000-12-26
NO995404D0 (no) 1999-11-04
ATE210661T1 (de) 2001-12-15
EP0983266B1 (en) 2001-12-12
KR20010012227A (ko) 2001-02-15
MXPA99009874A (es) 2004-09-30

Similar Documents

Publication Publication Date Title
PT860428E (pt) Compostos pirimidiona
IS5479A (is) Efnasambönd
IS5478A (is) Efnasambönd
IS5477A (is) Efnasambönd
ID22850A (id) Senyawa-senyawa pirazina
IS5354A (is) Ný efnasambönd
NO994877D0 (no) Kalsilytiske forbindelser
EE200000321A (et) Uudsed ühendid
ID20323A (id) Senyawa-senyawa triazinilaminostilbena
NO994900D0 (no) Forbindelser
NO995404D0 (no) Forbindelser
IS5323A (is) Efnasambönd
ID22983A (id) Senyawa-senyawa fluorometoksimino
IS5211A (is) Efnasambönd
DE69737634D1 (de) Insektizide oxadiazinverbindungen
SE9702775D0 (sv) Novel compounds
SE9701397D0 (sv) Compounds
ID21202A (id) Senyawa heterosiklik
ID18388A (id) Senyawa-senyawa heterosiklik
SE9701964D0 (sv) Compounds
SE9704837D0 (sv) New compounds
SE9702535D0 (sv) New compounds
SE9702696D0 (sv) New compounds
SE9704838D0 (sv) New compounds
SE9703225D0 (sv) new compounds